Skip to Main Content

Paper Details

Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.
Kidney360
15
2022
AKI, Acute Kidney Injury, CCL14, KDIGO, Patients, Severe, Urinary C-C Motif Chemokine Ligand 14, Urinary C-C motif chemokine ligand 14, critically, patient, patients
Acute Kidney Injury, Biological Assay, Chemokines, CC, Humans, Ligands, Renal Replacement Therapy
Author NameAffiliation
Jay L KoynerUniversity of Chicago
Lakhmir S ChawlaVeterans Affairs Medical Center
Azra BihoracUniversity of Florida
Azra BihoracUniversity of Florida
Kyle J GunnersonUniversity of Michigan Health, Michigan Center for Integrative Research in Critical Care (MCIRCC) ann arbor
Rebecca SchroederDuke University School of Medicine
Sevag DemirjianCleveland Clinic
Luke E HodgsonWorthing Hospital, University Hospitals Sussex
Jennifer A FreyOhio State University
Scott T WilberMount Carmel East Hospital
J Patrick KampfInc.
Thomas KwanInc.
Paul McPhersonInc.
John A KellumCenter for Critical Care Nephrology, University of Pittsburgh
  • 1 - 14

Datasets

Release 1.2